-
Venezuela receives first shipment of Cuban coronavirus vaccine
firstwordpharma
June 25, 2021
Venezuela’s vice president Delcy Rodriguez said the country received its first shipment of doses of Cuba's Abdala COVID-19 vaccine on Thursday, as reported in This is Money.
-
Rash, Itch After COVID Vaccine Rare & Quickly Resolves
drugs
June 24, 2021
Rashes, itchiness and other skin problems can develop after people receive COVID-19 vaccines, but such problems are rare and go away quickly, new research shows.
-
Study Suggests COVID Vaccine Booster Shots Will Be Needed
drugs
June 24, 2021
One dose of a two-dose mRNA COVID-19 vaccine is enough to protect previously infected people, but it's likely they and everyone with two doses will still require booster shots at a later date, a new study suggests.
-
Japan mulls approving AstraZeneca COVID vaccine for people 18 and over
firstwordpharma
June 24, 2021
According to sources, Japan is considering approving the use of AstraZeneca's COVID-19 vaccine for people aged 18 or over, as reported Kyodo News+ on Wednesday.
-
SAHPRA and the Sinopharm Vaccine
firstwordpharma
June 24, 2021
SAHPRA has received documentation for the Sinopharm vaccine developed by the China National Pharmaceutical Group in China.
-
Siemens and BioNTech expand their collaboration for global vaccine production
firstwordpharma
June 24, 2021
Siemens supplies the latest automation and digitalization technology for the production of Covid-19 vaccines
-
COVID-19 Vaccine Coverage in U.S. Highest Among ≥65-Year-Olds
drugs
June 23, 2021
COVID-19 vaccine coverage is 80.0 percent among those aged 65 years and older, while 34.0 percent of those aged 18 to 39 years report having received a COVID-19 vaccine, according to two studies published in the June 21 early-release issue
-
Astrazeneca COVID-19 vaccine effective against variants found in India
firstwordpharma
June 23, 2021
AstraZeneca, citing a study, said its COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, as reported by U.S. News & World Report.
-
Novavax Statement on Completion of the National Research Council of Canada Biologics Manufacturing Centre
firstwordpharma
June 23, 2021
The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry announced today that construction of the new Biologics Manufacturing Centre (BMC) at the National Research Council of Canada's (NRC)’s Royalmount location.
-
U.S. likely to miss July 4 COVID-19 vaccine target, White House says
firstwordpharma
June 23, 2021
The US will likely fail to meet President Joe Biden's goal to deliver at least one COVID-19 vaccine to 70% of adults by July 4, as reported This is Money on Tuesday.